APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 1 Diabetes (T1D)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Type 1 Diabetes (T1D) Market Outlook and Growth Opportunities 2026

Report ID 174043930422 December 2025192 pages

Choose your research edition.

Industry ResearchType 1 Diabetes (T1D) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 1 Diabetes (T1D) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Type 1 Diabetes (T1D) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 1 Diabetes (T1D) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 1 Diabetes (T1D) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Type 1 Diabetes (T1D) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Type 1 Diabetes (T1D) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Type 1 Diabetes (T1D) market include Janssen, Sanofi, Sanofi, Novo Nordisk, Merck, Eli Lilly, Samsung Bioepis, Lexicon and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Type 1 Diabetes (T1D) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Type 1 Diabetes (T1D) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Type 1 Diabetes (T1D) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Type 1 Diabetes (T1D) market size, projected growth trends, production technologies, key applications, and end-use industries.

Type 1 Diabetes (T1D) Segment by Company

Janssen

Sanofi

Sanofi

Novo Nordisk

Merck

Eli Lilly

Samsung Bioepis

Lexicon

Bristol-Myers Squibb

Boehringer Ingelheim

Biocon

Astellas

Type 1 Diabetes (T1D) Segment by Type

Long Acting Insulin Analogs

Premix Insulin Analogs

Rapid Acting Insulin Analogs

Type 1 Diabetes (T1D) Segment by Application

Children

Adults

Type 1 Diabetes (T1D) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Type 1 Diabetes (T1D) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Type 1 Diabetes (T1D) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Type 1 Diabetes (T1D) significant trends, drivers, influence factors in global and regions.

6. To analyze Type 1 Diabetes (T1D) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 1 Diabetes (T1D) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 1 Diabetes (T1D) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 1 Diabetes (T1D).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Type 1 Diabetes (T1D) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Type 1 Diabetes (T1D) industry.

Chapter 3: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Type 1 Diabetes (T1D) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Type 1 Diabetes (T1D) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Type 1 Diabetes (T1D) Industry Trends Table 2. Type 1 Diabetes (T1D) Industry Drivers Table 3. Type 1 Diabetes (T1D) Industry Opportunities and Challenges Table 4. Type 1 Diabetes (T1D) Industry Restraints Table 5. Global Type 1 Diabetes (T1D) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Type 1 Diabetes (T1D) Revenue Share by Company (2021-2026) Table 7. Global Type 1 Diabetes (T1D) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Type 1 Diabetes (T1D) Sales Volume Share by Company (2021-2026) Table 9. Global Type 1 Diabetes (T1D) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Type 1 Diabetes (T1D) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Type 1 Diabetes (T1D) Key Company Manufacturing Base & Headquarters Table 12. Global Type 1 Diabetes (T1D) Company, Product Type & Application Table 13. Global Type 1 Diabetes (T1D) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Type 1 Diabetes (T1D) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Long Acting Insulin Analogs Table 18. Significant Companies of Premix Insulin Analogs Table 19. Significant Companies of Rapid Acting Insulin Analogs Table 20. Global Type 1 Diabetes (T1D) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Type 1 Diabetes (T1D) Sales Volume by Type (2021-2026) & (k units) Table 22. Global Type 1 Diabetes (T1D) Sales Volume by Type (2027-2032) & (k units) Table 23. Global Type 1 Diabetes (T1D) Sales Volume Share by Type (2021-2026) Table 24. Global Type 1 Diabetes (T1D) Sales Volume Share by Type (2027-2032) Table 25. Global Type 1 Diabetes (T1D) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Type 1 Diabetes (T1D) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Type 1 Diabetes (T1D) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Type 1 Diabetes (T1D) Sales Value Share by Type (2021-2026) Table 29. Global Type 1 Diabetes (T1D) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Children Table 31. Significant Companies of Adults Table 32. Global Type 1 Diabetes (T1D) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Type 1 Diabetes (T1D) Sales Volume by Application (2021-2026) & (k units) Table 34. Global Type 1 Diabetes (T1D) Sales Volume by Application (2027-2032) & (k units) Table 35. Global Type 1 Diabetes (T1D) Sales Volume Share by Application (2021-2026) Table 36. Global Type 1 Diabetes (T1D) Sales Volume Share by Application (2027-2032) Table 37. Global Type 1 Diabetes (T1D) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Type 1 Diabetes (T1D) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Type 1 Diabetes (T1D) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Type 1 Diabetes (T1D) Sales Value Share by Application (2021-2026) Table 41. Global Type 1 Diabetes (T1D) Sales Value Share by Application (2027-2032) Table 42. Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Type 1 Diabetes (T1D) Sales by Region (2021-2026) & (k units) Table 44. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2021-2026) Table 45. Global Type 1 Diabetes (T1D) Sales by Region (2027-2032) & (k units) Table 46. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2027-2032) Table 47. Global Type 1 Diabetes (T1D) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Type 1 Diabetes (T1D) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Type 1 Diabetes (T1D) Sales Value Share by Region (2021-2026) Table 50. Global Type 1 Diabetes (T1D) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Type 1 Diabetes (T1D) Sales Value Share by Region (2027-2032) Table 52. Global Type 1 Diabetes (T1D) Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Type 1 Diabetes (T1D) Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Type 1 Diabetes (T1D) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 57. Global Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2026) Table 58. Global Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 59. Global Type 1 Diabetes (T1D) Sales Market Share by Country (2027-2032) Table 60. Global Type 1 Diabetes (T1D) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Type 1 Diabetes (T1D) Sales Value Market Share by Country (2021-2026) Table 62. Global Type 1 Diabetes (T1D) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Type 1 Diabetes (T1D) Sales Value Market Share by Country (2027-2032) Table 64. Janssen Company Information Table 65. Janssen Business Overview Table 66. Janssen Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Janssen Type 1 Diabetes (T1D) Product Portfolio Table 68. Janssen Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 73. Sanofi Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 78. Sanofi Recent Development Table 79. Novo Nordisk Company Information Table 80. Novo Nordisk Business Overview Table 81. Novo Nordisk Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio Table 83. Novo Nordisk Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Merck Type 1 Diabetes (T1D) Product Portfolio Table 88. Merck Recent Development Table 89. Eli Lilly Company Information Table 90. Eli Lilly Business Overview Table 91. Eli Lilly Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Eli Lilly Type 1 Diabetes (T1D) Product Portfolio Table 93. Eli Lilly Recent Development Table 94. Samsung Bioepis Company Information Table 95. Samsung Bioepis Business Overview Table 96. Samsung Bioepis Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio Table 98. Samsung Bioepis Recent Development Table 99. Lexicon Company Information Table 100. Lexicon Business Overview Table 101. Lexicon Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Lexicon Type 1 Diabetes (T1D) Product Portfolio Table 103. Lexicon Recent Development Table 104. Bristol-Myers Squibb Company Information Table 105. Bristol-Myers Squibb Business Overview Table 106. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio Table 108. Bristol-Myers Squibb Recent Development Table 109. Boehringer Ingelheim Company Information Table 110. Boehringer Ingelheim Business Overview Table 111. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio Table 113. Boehringer Ingelheim Recent Development Table 114. Biocon Company Information Table 115. Biocon Business Overview Table 116. Biocon Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Biocon Type 1 Diabetes (T1D) Product Portfolio Table 118. Biocon Recent Development Table 119. Astellas Company Information Table 120. Astellas Business Overview Table 121. Astellas Type 1 Diabetes (T1D) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Astellas Type 1 Diabetes (T1D) Product Portfolio Table 123. Astellas Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Type 1 Diabetes (T1D) Distributors List Table 127. Type 1 Diabetes (T1D) Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Type 1 Diabetes (T1D) Product Image Figure 2. Global Type 1 Diabetes (T1D) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Type 1 Diabetes (T1D) Sales (2021-2032) & (k units) Figure 5. Global Type 1 Diabetes (T1D) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Type 1 Diabetes (T1D) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Long Acting Insulin Analogs Image Figure 10. Premix Insulin Analogs Image Figure 11. Rapid Acting Insulin Analogs Image Figure 12. Global Type 1 Diabetes (T1D) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Type 1 Diabetes (T1D) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Type 1 Diabetes (T1D) Sales Volume Share by Type (2021-2032) Figure 15. Global Type 1 Diabetes (T1D) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Type 1 Diabetes (T1D) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Type 1 Diabetes (T1D) Sales Value Share by Type (2021-2032) Figure 18. Children Image Figure 19. Adults Image Figure 20. Global Type 1 Diabetes (T1D) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Type 1 Diabetes (T1D) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Type 1 Diabetes (T1D) Sales Volume Share by Application (2021-2032) Figure 23. Global Type 1 Diabetes (T1D) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Type 1 Diabetes (T1D) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Type 1 Diabetes (T1D) Sales Value Share by Application (2021-2032) Figure 26. Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Type 1 Diabetes (T1D) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Type 1 Diabetes (T1D) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Type 1 Diabetes (T1D) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Type 1 Diabetes (T1D) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Type 1 Diabetes (T1D) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Type 1 Diabetes (T1D) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Type 1 Diabetes (T1D) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Type 1 Diabetes (T1D) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Type 1 Diabetes (T1D) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Type 1 Diabetes (T1D) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Type 1 Diabetes (T1D) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs
  • Rapid Acting Insulin Analogs
Applications
  • Children
  • Adults
Companies covered
  • Janssen
  • Sanofi
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Samsung Bioepis
  • Lexicon
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Biocon
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Type 1 Diabetes (T1D) Sales Value (2021-2032)
  4. 1.2.2 Global Type 1 Diabetes (T1D) Sales Volume (2021-2032)
  5. 1.2.3 Global Type 1 Diabetes (T1D) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Type 1 Diabetes (T1D) Market Dynamics
  1. 2.1 Type 1 Diabetes (T1D) Industry Trends
  2. 2.2 Type 1 Diabetes (T1D) Industry Drivers
  3. 2.3 Type 1 Diabetes (T1D) Industry Opportunities and Challenges
  4. 2.4 Type 1 Diabetes (T1D) Industry Restraints
3 Type 1 Diabetes (T1D) Market by Company
  1. 3.1 Global Type 1 Diabetes (T1D) Company Revenue Ranking in 2025
  2. 3.2 Global Type 1 Diabetes (T1D) Revenue by Company (2021-2026)
  3. 3.3 Global Type 1 Diabetes (T1D) Sales Volume by Company (2021-2026)
  4. 3.4 Global Type 1 Diabetes (T1D) Average Price by Company (2021-2026)
  5. 3.5 Global Type 1 Diabetes (T1D) Company Ranking (2024-2026)
  6. 3.6 Global Type 1 Diabetes (T1D) Company Manufacturing Base and Headquarters
  7. 3.7 Global Type 1 Diabetes (T1D) Company Product Type and Application
  8. 3.8 Global Type 1 Diabetes (T1D) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Type 1 Diabetes (T1D) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Type 1 Diabetes (T1D) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Type 1 Diabetes (T1D) Market by Type
  1. 4.1 Type 1 Diabetes (T1D) Type Introduction
  2. 4.1.1 Long Acting Insulin Analogs
  3. 4.1.2 Premix Insulin Analogs
  4. 4.1.3 Rapid Acting Insulin Analogs
  5. 4.2 Global Type 1 Diabetes (T1D) Sales Volume by Type
  6. 4.2.1 Global Type 1 Diabetes (T1D) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Type 1 Diabetes (T1D) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Type 1 Diabetes (T1D) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Type 1 Diabetes (T1D) Sales Value by Type
  10. 4.3.1 Global Type 1 Diabetes (T1D) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Type 1 Diabetes (T1D) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Type 1 Diabetes (T1D) Sales Value Share by Type (2021-2032)
5 Type 1 Diabetes (T1D) Market by Application
  1. 5.1 Type 1 Diabetes (T1D) Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Type 1 Diabetes (T1D) Sales Volume by Application
  5. 5.2.1 Global Type 1 Diabetes (T1D) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Type 1 Diabetes (T1D) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Type 1 Diabetes (T1D) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Type 1 Diabetes (T1D) Sales Value by Application
  9. 5.3.1 Global Type 1 Diabetes (T1D) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Type 1 Diabetes (T1D) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Type 1 Diabetes (T1D) Sales Value Share by Application (2021-2032)
6 Type 1 Diabetes (T1D) Regional Sales and Value Analysis
  1. 6.1 Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Type 1 Diabetes (T1D) Sales by Region (2021-2032)
  3. 6.2.1 Global Type 1 Diabetes (T1D) Sales by Region: 2021-2026
  4. 6.2.2 Global Type 1 Diabetes (T1D) Sales by Region (2027-2032)
  5. 6.3 Global Type 1 Diabetes (T1D) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Type 1 Diabetes (T1D) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Type 1 Diabetes (T1D) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Type 1 Diabetes (T1D) Sales Value by Region (2027-2032)
  9. 6.5 Global Type 1 Diabetes (T1D) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Type 1 Diabetes (T1D) Sales Value (2021-2032)
  12. 6.6.2 North America Type 1 Diabetes (T1D) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Type 1 Diabetes (T1D) Sales Value (2021-2032)
  15. 6.7.2 Europe Type 1 Diabetes (T1D) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Type 1 Diabetes (T1D) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Type 1 Diabetes (T1D) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Type 1 Diabetes (T1D) Sales Value (2021-2032)
  21. 6.9.2 South America Type 1 Diabetes (T1D) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Type 1 Diabetes (T1D) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Type 1 Diabetes (T1D) Sales Value Share by Country, 2025 VS 2032
7 Type 1 Diabetes (T1D) Country-level Sales and Value Analysis
  1. 7.1 Global Type 1 Diabetes (T1D) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Type 1 Diabetes (T1D) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Type 1 Diabetes (T1D) Sales by Country (2021-2032)
  4. 7.3.1 Global Type 1 Diabetes (T1D) Sales by Country (2021-2026)
  5. 7.3.2 Global Type 1 Diabetes (T1D) Sales by Country (2027-2032)
  6. 7.4 Global Type 1 Diabetes (T1D) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Type 1 Diabetes (T1D) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Type 1 Diabetes (T1D) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Type 1 Diabetes (T1D) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Type 1 Diabetes (T1D) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Type 1 Diabetes (T1D) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen
  2. 8.1.1 Janssen Company Information
  3. 8.1.2 Janssen Business Overview
  4. 8.1.3 Janssen Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
  6. 8.1.5 Janssen Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novo Nordisk
  20. 8.4.1 Novo Nordisk Company Information
  21. 8.4.2 Novo Nordisk Business Overview
  22. 8.4.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
  24. 8.4.5 Novo Nordisk Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Type 1 Diabetes (T1D) Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Samsung Bioepis
  38. 8.7.1 Samsung Bioepis Company Information
  39. 8.7.2 Samsung Bioepis Business Overview
  40. 8.7.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
  42. 8.7.5 Samsung Bioepis Recent Developments
  43. 8.8 Lexicon
  44. 8.8.1 Lexicon Company Information
  45. 8.8.2 Lexicon Business Overview
  46. 8.8.3 Lexicon Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
  48. 8.8.5 Lexicon Recent Developments
  49. 8.9 Bristol-Myers Squibb
  50. 8.9.1 Bristol-Myers Squibb Company Information
  51. 8.9.2 Bristol-Myers Squibb Business Overview
  52. 8.9.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
  61. 8.11 Biocon
  62. 8.11.1 Biocon Company Information
  63. 8.11.2 Biocon Business Overview
  64. 8.11.3 Biocon Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
  66. 8.11.5 Biocon Recent Developments
  67. 8.12 Astellas
  68. 8.12.1 Astellas Company Information
  69. 8.12.2 Astellas Business Overview
  70. 8.12.3 Astellas Type 1 Diabetes (T1D) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
  72. 8.12.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Type 1 Diabetes (T1D) Value Chain Analysis
  2. 9.1.1 Type 1 Diabetes (T1D) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Type 1 Diabetes (T1D) Sales Mode & Process
  6. 9.2 Type 1 Diabetes (T1D) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Type 1 Diabetes (T1D) Distributors
  9. 9.2.3 Type 1 Diabetes (T1D) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst